Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients

OBJECTIVE: There is no recommendation for the use of disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) who developed cancer. We examined changes in the DMARDs prescription patterns associated with cancer diagnosis in RA patients. METHODS: We reviewed the medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Young Bin, Jeong, Seung Min, Park, Yune-Jung, Kim, Ki-Jo, Park, Kyung-Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324922/
https://www.ncbi.nlm.nih.gov/pubmed/37475975
http://dx.doi.org/10.4078/jrd.2022.29.3.162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324922/
https://www.ncbi.nlm.nih.gov/pubmed/37475975
http://dx.doi.org/10.4078/jrd.2022.29.3.162

Ejemplares similares